Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jun 28;131(26):2989-2992.
doi: 10.1182/blood-2018-02-832360. Epub 2018 May 16.

Prognostic factors influencing survival after allogeneic transplantation for AML/MDS patients with TP53 mutations

Stefan O Ciurea  1 , Abhishek Chilkulwar  1 , Rima M Saliba  1 , Julianne Chen  1 , Gabriela Rondon  1 , Keyur P Patel  2 , Haitham Khogeer  2 , Abdul R Shah  1 , Brion V Randolph  1 , Jorge M Ramos Perez  1 , Uday Popat  1 , Chitra M Hosing  1 , Qaiser Bashir  1 , Rohtesh Mehta  1 , Gheath Al-Atrash  1 , Jin Im  1 , Issa F Khouri  1 , Partow Kebriaei  1 , Richard E Champlin  1
Affiliations

Prognostic factors influencing survival after allogeneic transplantation for AML/MDS patients with TP53 mutations

Stefan O Ciurea et al. Blood. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest disclosure: The authors declare no competing financial interests.

Figures

Figure 1.
Figure 1.
OS based on the number of risk factors.
See this image and copyright information in PMC

Comment on

References

    1. Schlenk RF, Döhner K, Mack S, et al. . Prospective evaluation of allogeneic hematopoietic stem-cell transplantation from matched related and matched unrelated donors in younger adults with high-risk acute myeloid leukemia: German-Austrian trial AMLHD98A. J Clin Oncol. 2010;28(30):4642-4648. - PubMed
    1. Baron F, Labopin M, Niederwieser D, et al. . Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Leukemia. 2012;26(12):2462-2468. - PubMed
    1. Poiré X, Labopin M, Maertens J, et al. . Allogeneic stem cell transplantation in adult patients with acute myeloid leukaemia and 17p abnormalities in first complete remission: a study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT). J Hematol Oncol. 2017;10(1):20. - PMC - PubMed
    1. Middeke JM, Fang M, Cornelissen JJ, et al. . Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation. Blood. 2014;123(19):2960-2967. - PubMed
    1. Fenaux P, Preudhomme C, Quiquandon I, et al. . Mutations of the P53 gene in acute myeloid leukaemia. Br J Haematol. 1992;80(2):178-183. - PubMed

MeSH terms

Substances